Gourt > Health > Pharmacy > Drugs and Medications > I > Irbesartan
Irbesartan (INN) (IPA: ) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of Sanofi Aventis). It is jointly marketed by Sanofi Aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro.
Clinical use
Indications
As with all angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. Irbesartan may also delay progression of diabetic nephropathy and is also indicated for the reduction of renal disease progression in patients with type 2 diabetes, hypertension and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours).Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3 More on [ Irbesartan ]
Avapro - Prescribing information for US residents from Sanofi Syntholabo.
Avapro - Warnings, precautions, and contraindications from Physician's Weekly.
Avapro - Consumer information including dosage, side effects and interactions from the PDR Family Guide.
Meta Description: [ Provides accurate, up-to-date information on Avapro including usage, dosage, side effects and interactions. All written for the consumer by healthcare profressionals. ]
DrugDigest: Irbesartan - Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available.
MEDLINEplus: Irbesartan - Features information about dosage, usage, warnings, and side effects.
Meta Description: [ Irbesartan (Systemic) ]
